Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Beliefs can regulate effects of nicotine on the human brain

  • Evolutionary approach reveals new clues toward understanding the roots of schizophrenia

  • Reviving drugs with anti-stroke potential, minus side effects

  • Shake it off? Not so easy for people with depression, new brain research suggests

  • Protein pathway involved in brain tumor stem cell growth identified

  • Enhancing studies on a possible blood biomarker for traumatic brain injury

  • Left or right? The brain knows before you move

  • Study challenges theory on unconscious memory system in the brain

  • Study challenges theory on unconscious memory system

  • Retinal swelling in premature infants tied to poorer neuro-development

  •